Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional F alpha sT study

Burmester G.; Nuesslein H.; von Hinueber U.; Detert J.; Richter C.; Kumke T.; Leunikava I.; Lendl U.; Fricke D.; Mueller-Ladner U.

首页> 外文期刊>Clinical and experimental rheumatology >Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional F alpha sT study

【24h】

Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional F alpha sT study

机译：德国现实类风湿性关节炎患者抗肿瘤坏死因子治疗抗肿瘤坏死因子治疗的有效性和安全性：非介入性F alpha St研究结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：客观的

著录项

来源
《Clinical and experimental rheumatology》 |2019年第5期|共10页
作者
Burmester G.; Nuesslein H.; von Hinueber U.; Detert J.; Richter C.; Kumke T.; Leunikava I.; Lendl U.; Fricke D.; Mueller-Ladner U.;
展开▼
作者单位

Charite Univ Med Berlin Dept Rheumatol &

Clin Immunol Berlin Germany;

Univ Erlangen Nurnberg Rheumatol Practice Erlangen Germany;

Charite Univ Med Berlin Dept Rheumatol &

Clin Immunol Berlin Germany;

UCB Pharma Monheim Germany;

UCB Pharma Monheim Germany;

UCB Pharma Monheim Germany;

UCB Pharma Monheim Germany;

Justus Liebig Univ Giessen Dept Rheumatol &

Clin Immunol Campus Kerckhoff Bad Nauheim Bad;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
rheumatoid arthritis; certolizumab pegol; efficacy; safety;

机译：类风湿性关节炎;Certolizumab Pegol;疗效;安全;

相似文献

外文文献
中文文献
专利

1. Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional F alpha sT study [J] . Burmester G., Nuesslein H., von Hinueber U., Clinical and experimental rheumatology . 2019,第5期

机译：德国现实类风湿性关节炎患者抗肿瘤坏死因子治疗抗肿瘤坏死因子治疗的有效性和安全性：非介入性F alpha St研究结果
2. The Effectiveness and Safety of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study [J] . Bessette Louis, Haraoui Boulos, Chow Andrew, The Journal of rheumatology . 2018,第7期

机译：Certolizumab PEGOL在加拿大实践环境中的类风湿性关节炎患者的有效性和安全性：非介入F-alphast的两年结果可以研究
3. Improvement in Work Productivity and Fatigue of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study [J] . Bessette Louis, Haraoui Boulos, Chow Andrew, The Journal of rheumatology . 2018,第7期

机译：加拿大实践环境中类风湿性关节炎患者中睾丸性关节炎患者的工作生产率和疲劳的提高：非介入F-alphast的两年结果可以研究
4. An MRI Study of Bone Erosions Healing in the Wrist and Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis [C] . Francesca Barbieri, Veronica Tomatis, Giuseppe Zampogna, International conference on image analysis and processing;International workshop on recent advances in digital security: biometrics and forensics;Workshop on color in texture and material recognition;Workshop on medical imaging in rheumatology: advanced applications for the analysis of inflammation and damage in the rheumatoid joint;Workshop on image-based smart city application;International workshop on multimedia assisted dietary management;Workshop on scene background modeling and initalization;workshop on image and video processing for quality of multimedia experience . 2015

机译：类风湿关节炎患者腕关节和掌指关节骨侵蚀愈合的MRI研究
5. Regulation of Tumor Necrosis Factor-alpha Signaling in Rheumatoid Arthritis Synovial Fibroblasts by Green Tea Polyphenol Epigallocatechin-3-gallate. [D] . Riegsecker, Sharayah. 2013

机译：绿茶多酚表没食子儿茶素-3-没食子酸酯对类风湿关节炎滑膜成纤维细胞中肿瘤坏死因子-α信号的调节。
6. Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study [O] . Louis Bessette, Boulos Haraoui, Andrew Chow, 2019

机译：在加拿大类风湿关节炎患者使用塞妥珠单抗聚乙二醇化的有效性和安全性：FαsT-CAN观察性研究的2年结果
7. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study [O] . Fleischmann, R, Vencovsky, J, van Vollenhoven, R F, 2008

机译：FAST4WARD研究表明，风湿性关节炎患者每4周使用一次certolizumab聚乙二醇单药治疗的有效性和安全性

Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional F alpha sT study

摘要

著录项

相似文献

相关主题

期刊订阅